All Stories

  1. Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects
  2. Ionization of tocopherols and tocotrienols in atmospheric pressure chemical ionization
  3. Evaluation of sequential Bayesian-based method development procedures for chromatographic problems involving one, two, and three analytes
  4. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
  5. Hydroxycarbamide in children with sickle cell anaemia after first-dose vs . chronic therapy: pharmacokinetics and predictive models for drug exposure
  6. How to model temporal changes in non-targeted metabolomics study? A Bayesian multilevel perspective
  7. Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants
  8. The pharmacokinetics of propofol in ICU patients undergoing long-term sedation
  9. Pharmacokinetics of sufentanil during long-term infusion in critically ill pediatric patients
  10. Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery
  11. Melatonin and clonidine premedication has similar impact on the pharmacokinetics and pharmacodynamics of propofol target controlled-infusions
  12. Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries
  13. The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats
  14. The simultaneous determination of hydrophobicity and dissociation constant by liquid chromatography–mass spectrometry
  15. Development and validation of UHPLC method for the determination of cyclosporine A in biological samples
  16. Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease
  17. The influence of the time of day on midazolam pharmacokinetics and pharmacodynamics in rabbits
  18. Determination of red blood cell age distribution by means of capillary electrophoresis
  19. Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children
  20. New supervised alignment method as a preprocessing tool for chromatographic data in metabolomic studies
  21. A new pH/organic modifier gradient RP HPLC method for convenient determination of lipophilicity and acidity of drugs as applied to established imidazoline agents
  22. Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics
  23. QSAR, QSPR and QSRR in Terms of 3-D-MoRSE Descriptors for In Silico Screening of Clofibric Acid Analogues
  24. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I–III patients
  25. Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery
  26. Gradient reversed-phase high-performance chromatography of ionogenic analytes
  27. Thermodynamic vs. extrathermodynamic modeling of chromatographic retention
  28. Influence of Time of Day on Propofol Pharmacokinetics and Pharmacodynamics in Rabbits
  29. Reversed-Phase TLC and HPLC Retention Data in Correlation Studies with in Silico Molecular Descriptors and Druglikeness Properties of Newly Synthesized Anticonvulsant Succinimide Derivatives
  30. Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
  31. Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations
  32. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients
  33. pH Gradient as a Tool for the Separation of Ionizable Analytes in Reversed-Phase High-Performance Chromatography
  34. Retention time and peak width in the combined pH/organic modifier gradient high performance liquid chromatography
  35. Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus
  36. Population Pharmacokinetic Modelling of Filgrastim in Healthy Adults following Intravenous and Subcutaneous Administrations
  37. Flow cytometric analysis of reticulocyte maturation after erythropoietin administration in rats
  38. The application of gradient reversed-phase high-performance liquid chromatography to the pKa and determination of polyprotic analytes
  39. Influence of pH on Retention in Linear Organic Modifier Gradient RP HPLC
  40. Flow cytometric assessment of homeostatic aging of reticulocytes in rats
  41. Method of determination of the reticulocyte age distribution from flow cytometry count by a structured-population model
  42. Double gradient of organic modifier nad pKa in RP HPLC
  43. Verification of the exponential model of body temperature decrease after death in pigs
  44. Prediction of Peptide Retention at Different HPLC Conditions from Multiple Linear Regression Models
  45. Combined pH/organic solvent gradient HPLC in analysis of forensic material
  46. Theoretical opportunities and actual limitations of pH gradient HPLC
  47. pH/Organic Solvent Double-Gradient Reversed-Phase HPLC
  48. pH gradient high-performance liquid chromatography: theory and applications
  49. High-throughput Evaluation of Lipophilicity and Acidity by New Gradient HPLC Methods
  50. Determination of pKaby pH Gradient Reversed-Phase HPLC
  51. pH Gradient Reversed-Phase HPLC